BPC 157 TB 500 Blend Simple Peptide Peptide Therapy bioworX BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Comparing TB 500 and BPC 157 Studies in Tissue Recovery When will the FDA reclassify BPC 157 to Category 1 Octagon AI